Is predicted to encode a protein with the following domains: BART domain; Cilia- and flagella-associated protein 36; BART domain superfamily; and The ARF-like 2 binding protein BART.
Is predicted to encode a protein with the following domains: BART domain; Cilia- and flagella-associated protein 36; BART domain superfamily; and The ARF-like 2 binding protein BART. Is an ortholog of C. elegans cfap-36.
Is predicted to encode a protein with the following domains: BART domain; Cilia- and flagella-associated protein 36; BART domain superfamily; and The ARF-like 2 binding protein BART. Is an ortholog of C. elegans cfap-36.
Is predicted to encode a protein with the following domains: BART domain; Cilia- and flagella-associated protein 36; BART domain superfamily; and The ARF-like 2 binding protein BART. Is an ortholog of C. elegans cfap-36.
Is predicted to encode a protein with the following domains: BART domain; Cilia- and flagella-associated protein 36; and The ARF-like 2 binding protein BART.
Is predicted to encode a protein with the following domains: BART domain; Cilia- and flagella-associated protein 36; and The ARF-like 2 binding protein BART.
Plasma membrane metalloid/H+ antiporter; member of bile/arsenite/riboflavin transporter (BART) superfamily; transports arsenite and antimonite; required for resistance to arsenic compounds; transcription is activated by Arr1p in the presence of arsenite; protein displays 10 transmembrane segments with cytoplasmically oriented N- and C-terminal domains
Enables gap junction channel activity. Involved in several processes, including cellular response to dexamethasone stimulus; cellular response to glucagon stimulus; and decidualization. Located in several cellular components, including astrocyte projection; gap junction; and lateral plasma membrane. Used to study hepatocellular carcinoma and lung adenocarcinoma. Biomarker of autoimmune thyroiditis; extrahepatic cholestasis; ischemia; sensorineural hearing loss; and urethral obstruction. Human ortholog(s) of this gene implicated in Bart-Pumphrey syndrome; Vohwinkel syndrome; autosomal dominant keratitis-ichthyosis-deafness syndrome; nonsyndromic deafness (multiple); and palmoplantar keratoderma-deafness syndrome. Orthologous to human GJB2 (gap junction protein beta 2); INTERACTS WITH 17alpha-ethynylestradiol; 17beta-estradiol; 17beta-estradiol 3-benzoate.